These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13788928)

  • 1. [Polyestradiol phosphate (estradurin) in prostate carcinoma].
    ZUERCHER P
    Helv Chir Acta; 1960 Oct; 27():500-5. PubMed ID: 13788928
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observation of polyestradiol phosphate (estradurin) in treatment of prostatic carcinoma.
    MOOKINI RK; KELLY EF
    J Urol; 1960 Jan; 83():72-3. PubMed ID: 14423802
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer of the prostate; further observations with estradurin (polyestradiol phosphate).
    GOODHOPE CD
    Postgrad Semin Am Urol Assoc North Cent; 1957; ():170-1. PubMed ID: 13554425
    [No Abstract]   [Full Text] [Related]  

  • 4. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
    Lindstedt E
    Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients.
    Stege R; Gunnarsson PO; Johansson CJ; Olsson P; Pousette A; Carlström K
    Prostate; 1996 May; 28(5):307-10. PubMed ID: 8610057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ESTROGEN-INDUCED CHANGES IN PROSTATE PATIENTS. PHYSICAL AND MENTAL EFFECTS IN 29 PATIENTS TREATED WITH ESTRADURIN-POLYESTRADIOL PHOSPHATE].
    PETERSEN P; ZINGG E
    Urol Int; 1965; 19():317-25. PubMed ID: 14316549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of advanced prostatic carcinoma using polyestradiol phosphate (Estradurin)].
    Bülow H
    Med Welt; 1980 Aug; 31(34):1215-7. PubMed ID: 6776381
    [No Abstract]   [Full Text] [Related]  

  • 8. Polyestradiol phosphate for carcinoma of the prostate: a clinical study.
    GOODHOPE CD
    J Urol; 1957 Feb; 77(2):312-4. PubMed ID: 13406884
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer.
    Norlén BJ; Fritjofsson A; Grönquist L; Gunnarsson PO; Johansson SA; Plym-Forshell G
    Eur Urol; 1987; 13(3):193-7. PubMed ID: 3609099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
    Lukkarinen O; Hammond GL; Kontturi M; Vihko R
    Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.
    Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E;
    J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyestradiol phosphate for carcinoma of the prostate: a clinical study.
    GOODHOPE CD
    Trans West Sect Am Urol Assoc; 1956; 23():53-5; discussion, 56. PubMed ID: 13401466
    [No Abstract]   [Full Text] [Related]  

  • 14. [PSYCHIC ESTROGEN EFFECTS IN MALES. PROSTATIC PATIENTS TREATED WITH POLYESTRADIOL PHOSPHATE (ESTRADURIN)].
    PETERSEN P
    Arch Psychiatr Nervenkr; 1964 Dec; 206():382-405. PubMed ID: 14345319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-biological aspects of several cases of carcinoma of the prostate treated with polyestradiol phosphate (PEP)].
    MOLINATTI GM; OLIVETTI M
    Minerva Med; 1959 Mar; 50(21):745-50. PubMed ID: 13656687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of amenorrhea with estradurin (polyestradiol phosphate)].
    HACKL H
    Sven Lakartidn; 1960 Jan; 57():247-69. PubMed ID: 13830718
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group.
    Lundgren R; Nordle O; Josefsson K
    J Urol; 1995 May; 153(5):1580-6. PubMed ID: 7714978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estradurin in the treatment of cancer of the prostate].
    BOURQUE JP
    Union Med Can; 1960 Aug; 89():1031-3. PubMed ID: 13803366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estradurin therapy in cancer of the prostate with metastses to the soft parts: a casuistic report].
    LUNDVALL O
    Sven Lakartidn; 1960 Jan; 57():112-7. PubMed ID: 14418950
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.
    Leinonen P; Hammond GL; Lukkarinen O; Vihko R
    Invest Urol; 1979 Jul; 17(1):24-7. PubMed ID: 571863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.